BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wiest R. Splanchnic and systemic vasodilation: the experimental models. J Clin Gastroenterol. 2007;41 Suppl 3:S272-S287. [PMID: 17975477 DOI: 10.1097/mcg.0b013e318157cb57] [Cited by in Crossref: 35] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Rizvi MR, Tauseef M, Shahid M, Babbar R, Fahim M, Sakhuja P, Sarin SK. Nitric oxide and prostaglandin as mediators in the pathogenesis of hyperkinetic circulatory state in a model of endotoxemia-induced portal hypertension. Hepatol Int 2013;7:622-35. [PMID: 26201795 DOI: 10.1007/s12072-012-9397-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Buechler C, Haberl EM, Rein-Fischboeck L, Aslanidis C. Adipokines in Liver Cirrhosis. Int J Mol Sci 2017;18:E1392. [PMID: 28661458 DOI: 10.3390/ijms18071392] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
3 Liedtke C, Luedde T, Sauerbruch T, Scholten D, Streetz K, Tacke F, Tolba R, Trautwein C, Trebicka J, Weiskirchen R. Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogenesis Tissue Repair. 2013;6:19. [PMID: 24274743 DOI: 10.1186/1755-1536-6-19] [Cited by in Crossref: 199] [Cited by in F6Publishing: 181] [Article Influence: 24.9] [Reference Citation Analysis]
4 Kukla M, Waluga M, Żorniak M, Berdowska A, Wosiewicz P, Sawczyn T, Bułdak RJ, Ochman M, Ziora K, Krzemiński T, Hartleb M. Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis. World J Gastroenterol 2017;23:2613-24. [PMID: 28465646 DOI: 10.3748/wjg.v23.i14.2613] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
5 Moller S, Henriksen JH, Bendtsen F. Pathogenetic background for treatment of ascites and hepatorenal syndrome. Hepatol Int. 2008;2:416-428. [PMID: 19669317 DOI: 10.1007/s12072-008-9100-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
6 Martell M, Coll M, Ezkurdia N, Raurell I, Genescà J. Physiopathology of splanchnic vasodilation in portal hypertension. World J Hepatol 2010;2:208-20. [PMID: 21160999 DOI: 10.4254/wjh.v2.i6.208] [Cited by in Crossref: 62] [Cited by in F6Publishing: 43] [Article Influence: 6.2] [Reference Citation Analysis]
7 Hennenberg M, Trebicka J, Stark C, Kohistani AZ, Heller J, Sauerbruch T. Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis. Br J Pharmacol. 2009;157:258-270. [PMID: 19338580 DOI: 10.1111/j.1476-5381.2009.00158.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 4.8] [Reference Citation Analysis]
8 Stankovic Z, Rössle M, Euringer W, Schultheiss M, Salem R, Barker A, Carr J, Langer M, Markl M, Collins JD. Effect of TIPS placement on portal and splanchnic arterial blood flow in 4-dimensional flow MRI. Eur Radiol. 2015;25:2634-2640. [PMID: 25850890 DOI: 10.1007/s00330-015-3663-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
9 Sastre E, Caracuel L, Prieto I, Llévenes P, Aller MÁ, Arias J, Balfagón G, Blanco-Rivero J. Decompensated liver cirrhosis and neural regulation of mesenteric vascular tone in rats: role of sympathetic, nitrergic and sensory innervations. Sci Rep 2016;6:31076. [PMID: 27484028 DOI: 10.1038/srep31076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
10 Sheen JM, Chen YC, Tain YL, Huang LT. Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model. Int J Mol Sci. 2014;15:3989-4006. [PMID: 24603538 DOI: 10.3390/ijms15033989] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]